The global oral controlled release drug delivery technology market is witnessing significant growth due to rising demand for advanced pharmaceutical formulations, improved patient compliance, and long-term treatment effectiveness for chronic diseases. Pharmaceutical companies are increasingly investing in innovative drug delivery systems that enable sustained therapeutic effects while...

NEWARK, DE/— The global oral controlled release drug delivery technology market is poised for substantial growth, projected to expand from USD 45.13 billion in 2026 to USD 90.45 billion by 2036, registering a CAGR of 7.20% during the forecast period, according to Future Market Insights (FMI). The market is witnessing accelerated demand due to the increasing prevalence of chronic...